Andreas Ziegler

6PUBLICATIONS
23CO-AUTHORS
Molecular targetsMetabolic medicineNeonatologyGene and molecular therapyNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland - part II - expert based recommendations for surveillance and management of side-effects.

|May 27, 2026
Interpretation of Pharmacometabolomics Results: Fingerprint of Drug Exposure or Confounder Effects? Insights from a Urinary Metabolomics Study with Voriconazole in Healthy Participants.

|Mar 28, 2026
Urinary Metabolomics Predict Acute Kidney Injury in Very-Low-Birth-Weight Infants with Patent Ductus Arteriosus.

Moritz Niesert, Claire Cannet, Alexander Fichtner

|Nov 24, 2025
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland-part I-systematic literature review and existing evidence.

Claudia Weiß, Katharina Vill, Matthias Baumann

|Nov 27, 2024
Identification of Biochemical Determinants for Diagnosis and Prediction of Severity in 5q Spinal Muscular Atrophy Using 1H-Nuclear Magnetic Resonance Metabolic Profiling in Patient-Derived Biofluids.

Afshin Saffari, Moritz Niesert, Claire Cannet

|Oct 21, 2021
1H-NMR-based metabolic profiling identifies non-invasive diagnostic and predictive urinary fingerprints in 5q spinal muscular atrophy.

Afshin Saffari, Claire Cannet, Astrid Blaschek

Pageof 1

Frequent Collaborators

3 joint publications

Moritz Niesert

3 joint publications

Georg F Hoffmann

2 joint publications

Claire Cannet

2 joint publications

Georg M Stettner